The US Food and Drug Administration will consider whether or not to stop the use of intravenous starch solutions to replace lost blood.
Advertisement
The Scientist
Most Recent
Patent expirations of one HIV drugs will make the disease cheaper—but also more cumbersome—to treat.
A slight flaw in a study on the effectiveness of a drug widely used to combat shock in critically injured patients almost gets a Danish researcher sued for millions.
Minnows living in water with psychoactive pharmaceuticals have autism-like gene expression profiles, pointing to an environmental trigger for the disorder.
Researchers create transgenic cells that may help camels produce milk full of therapeutic proteins.
Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of d
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
An incorrect isomer of the kinase inhibitor bosutinib is circulating in the biomedical research community, potentially throwing doubt on study results.
Large molecules are more likely to make it to market these days than small molecules, according to new reports.
Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
